294 related articles for article (PubMed ID: 31597297)
1. Cellular Processing of the ABCG2 Transporter-Potential Effects on Gout and Drug Metabolism.
Mózner O; Bartos Z; Zámbó B; Homolya L; Hegedűs T; Sarkadi B
Cells; 2019 Oct; 8(10):. PubMed ID: 31597297
[TBL] [Abstract][Full Text] [Related]
2. Medically Important Alterations in Transport Function and Trafficking of ABCG2.
Homolya L
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801813
[TBL] [Abstract][Full Text] [Related]
3. Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression.
Zámbó B; Bartos Z; Mózner O; Szabó E; Várady G; Poór G; Pálinkás M; Andrikovics H; Hegedűs T; Homolya L; Sarkadi B
Sci Rep; 2018 May; 8(1):7487. PubMed ID: 29749379
[TBL] [Abstract][Full Text] [Related]
4. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
[TBL] [Abstract][Full Text] [Related]
5. The ABCG2/BCRP transporter and its variants - from structure to pathology.
Sarkadi B; Homolya L; Hegedűs T
FEBS Lett; 2020 Dec; 594(23):4012-4034. PubMed ID: 33015850
[TBL] [Abstract][Full Text] [Related]
6. Functional Characterization of Clinically-Relevant Rare Variants in
Toyoda Y; Mančíková A; Krylov V; Morimoto K; Pavelcová K; Bohatá J; Pavelka K; Pavlíková M; Suzuki H; Matsuo H; Takada T; Stiburkova B
Cells; 2019 Apr; 8(4):. PubMed ID: 31003562
[TBL] [Abstract][Full Text] [Related]
7. Effects of the gout-causing Q141K polymorphism and a CFTR ΔF508 mimicking mutation on the processing and stability of the ABCG2 protein.
Sarankó H; Tordai H; Telbisz Á; Özvegy-Laczka C; Erdős G; Sarkadi B; Hegedűs T
Biochem Biophys Res Commun; 2013 Jul; 437(1):140-5. PubMed ID: 23800412
[TBL] [Abstract][Full Text] [Related]
8. The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.
Eckenstaler R; Benndorf RA
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206432
[TBL] [Abstract][Full Text] [Related]
9. ABCG2 as a therapeutic target candidate for gout.
Fujita K; Ichida K
Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of ABCG2 and its impact on clinical relevance.
Zhang W; Sun S; Zhang W; Shi Z
Biochem Biophys Res Commun; 2018 Sep; 503(2):408-413. PubMed ID: 29964015
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia.
Pálinkás M; Szabó E; Kulin A; Mózner O; Rásonyi R; Juhász P; Nagy K; Várady G; Vörös D; Zámbó B; Sarkadi B; Poór G
Clin Exp Med; 2023 Aug; 23(4):1277-1284. PubMed ID: 35939175
[TBL] [Abstract][Full Text] [Related]
12. Transmembrane Domain Single-Nucleotide Polymorphisms Impair Expression and Transport Activity of ABC Transporter ABCG2.
Sjöstedt N; van den Heuvel JJMW; Koenderink JB; Kidron H
Pharm Res; 2017 Aug; 34(8):1626-1636. PubMed ID: 28281205
[TBL] [Abstract][Full Text] [Related]
13. Cellular expression and function of naturally occurring variants of the human ABCG2 multidrug transporter.
Zámbó B; Mózner O; Bartos Z; Török G; Várady G; Telbisz Á; Homolya L; Orbán TI; Sarkadi B
Cell Mol Life Sci; 2020 Jan; 77(2):365-378. PubMed ID: 31254042
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive analysis of the association of common variants of ABCG2 with gout.
Yu KH; Chang PY; Chang SC; Wu-Chou YH; Wu LA; Chen DP; Lo FS; Lu JJ
Sci Rep; 2017 Aug; 7(1):9988. PubMed ID: 28855613
[TBL] [Abstract][Full Text] [Related]
15. Identification of ABCG2 dysfunction as a major factor contributing to gout.
Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Takada Y; Okada C; Sakurai Y; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1098-104. PubMed ID: 22132963
[TBL] [Abstract][Full Text] [Related]
16. Single-nucleotide polymorphisms in a short basic motif in the ABC transporter ABCG2 disable its trafficking out of endoplasmic reticulum and reduce cell resistance to anticancer drugs.
Zhang W; Yang Y; Dong Z; Shi Z; Zhang JT
J Biol Chem; 2019 Dec; 294(52):20222-20232. PubMed ID: 31719146
[TBL] [Abstract][Full Text] [Related]
17. Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules.
Woodward OM; Tukaye DN; Cui J; Greenwell P; Constantoulakis LM; Parker BS; Rao A; Köttgen M; Maloney PC; Guggino WB
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5223-8. PubMed ID: 23493553
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2).
Meyer zu Schwabedissen HE; Kroemer HK
Handb Exp Pharmacol; 2011; (201):325-71. PubMed ID: 21103975
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of
Duong NT; Ngoc NT; Thang NTM; Phuong BTH; Nga NT; Tinh ND; Quynh DH; Ton ND; Hai NV
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30621105
[No Abstract] [Full Text] [Related]
20. [ROLE OF SLC2A9 AND ABCG2 GENE POLYMORPHISMS IN ORIGIN OF HYPERURICEMIA AND GOUT].
Fadieieva A; Prystupa L; Pogorelova O; Kirichenko N; Dudchenko I
Georgian Med News; 2016 Mar; (252):79-83. PubMed ID: 27119840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
